疾控中心和林业发展局将在2026年3月会议上审查COVID-19和流感疫苗数据。 CDC and FDA to review COVID-19 and flu vaccine data in March 2026 meetings.

疾控中心免疫做法咨询委员会将于3月18日至19日举行会议,讨论COVID-19疫苗可能产生的副作用和长长的COVID,并可能就这些问题提出建议。 The CDC’s Advisory Committee on Immunization Practices will meet March 18–19 to discuss potential COVID-19 vaccine side effects and long COVID, with possible recommendations on these issues. 会议是在2025年所有委员都被解雇后委员会重组之后举行的。 The meeting follows the committee’s reconstitution in 2025 after all members were dismissed. 同时,林业发展局将召集3月12日疫苗咨询小组,根据全球监测数据,就2026-2027年季节的流感疫苗菌株提出建议。 Meanwhile, the FDA will convene its vaccines advisory panel March 12 to recommend flu vaccine strains for the 2026–2027 season based on global surveillance data. 这两次会议的目的是为公共卫生指导提供信息,尽管最近更新的疫苗仍然对通信清晰度和科学透明度表示关切。 Both meetings aim to inform public health guidance, though concerns remain about communication clarity and scientific transparency in recent vaccine updates.